Excipients & Specialty Ingredients
Company Overview
About
Sinocompound is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:China
Founded:1991
Employees:1,961
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Global
Regulatory Approvals
Drug Approval 86KXWS
EMA · #APR-TQ2B97GT · 2019-10-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-8W9YWJEQ
Issued: 2020-10-11
Expires: 2025-11-06
Health Canada GMP
Health Canada
Cert #: CERT-67OUZKTI
Issued: 2020-06-10
Expires: 2025-03-20
Loading CDMO intelligence...
Key facts about Sinocompound
- Sinocompound is headquartered in China.
- Sinocompound was founded in 1991.
- Sinocompound has 1,961 employees.
- Sinocompound's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Sinocompound
Directory pages this company appears in, each with the full list of matching manufacturers.